While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading to an early diagnosis of essential thrombocythemia. Despite initial ...

Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells ...

Patients with essential thrombocythemia faced an average delay of 26.5 months between their first high platelet count and diagnosis. Patients experienced a significant delay in receiving an essential ...

Hemorrhagic events post-diagnosis in patients with ET significantly increase mortality risk, more than thrombosis or disease progression. Intracranial hemorrhage is the most lethal bleeding ...

The predictive value of the MASCC score in patients with febrile neutropenia. Effects of various non-demographic variables on mortality and length of stay in stroke patients with history of ET.

If you have the JAK2 V617F mutation, are aged 18-74 years old, do not smoke, do not have any known autoimmune disease, and attend medical checks at UAB regularly, you may be eligible for our study!

Over the past 35 years, interferons have been explored in various formulations for the management of Philadelphia chromosome–negative myeloproliferative neoplasms (MPNs), such as essential ...